Strep/Mono/Vectors Flashcards
Streptococcus Pyogenes (Group A Strep): most common diseases
Pharyngitis
Scarlet Fever
Impetigo
Necrotizing Fascitis
Acute rheumatic fever*
Poststreptococcal glomerulonephritis*
*more important in terms of morbidity and mortality worldwide
S. pyogenes characteristics in Micro
Gram positive coccus
Beta-hemolytic
S. pyogenes: less common diseases
Otitis media in children
Sinusitis in adults
Osteomylitis
Septic arthritis
Neonatal septicemia
Pneumonia (rare)
Necrotizing Fasciitis
S. pyogenes
“flesh eating bacteria”
Rare, destroys skin and soft tissue, including fat and tissues surrounding muscles (fascia)
S. pyogenes morphological characteristics
Classified based on immunologic action of cell wall carbohydrates. Lancefield serogroups A-H, K & O.
Fimbriae
-structures near plasma membrane, project through cell wall and capsule, contain important
-EX: M Protein is a major virulence factor, found in association with hyaluronic capsule, it inhibit phagocytosis. Antibody against M protein provides type specific immunity
Lipoteichoic Acid
-important to adherence to human epithelium and initiation of infection
(Margin notes: S. pyogenes contains many antigenic structural components and produces several antigenic enzymes, which of which may elicit a specific antibody response from the infected host)
S. pyogenes Extracellular Products - Two Hemolysins
Streptolysin O (SLO): oxygen labile enzyme, binds to RBC membranes, allows submicroscopic holes in membranes and Hgb diffuses from cells. Antibody response to SLO is the most commonly used indicator of recent strep infection.
Streptolysin S: oxygen-stable, responsible for beta-hemolysis of blood agar, disrupts RBC membrane selective permeability (causing osmotic lysis), not antigenic
S. pyogenes extracellular products (non-hemolysins, facilitate rapid spread)
Hyaluronidase “spreading factor”: breaks down hyaluronic acid found in connective tissue
DNases A, B, C & D (immunologically distinct)
Streptokinase: enzyme that dissolves clots by coverting plasminogen to plasmin
Erythrogenic toxin: elaborated by scarlet fever associated strains (characteristic rash)
S. pyogenes Epidemiology
One of the most common human pathogens
Found in respiratory tract, spread by contact with large droplets, crowding increases spread (Upper resp. infections common in school age kids)
Some asymptomatic carriers
Rheumatic fever a major complication of infection (decreased in US due to early treatments)
S. pyogenes - Upper Respiratory Infection, Viral Pharyngitis symptoms
Both have age dependent manifestations
Infant/young child: rhinorrhea, coughing fever, vomit, anorexia
Kids >3 years: classic strep pharyngitis
S. pyogenes - Impetigo/Cellulitis signs and symptoms
Skin infection begins as papule
Lesion may itch, eventually crusting over and healing
Cellulitis - subq infection, warm, tender
S. pyogenes - Scarlet Fever signs & symptoms
Result of pharyngeal infection with a strain of group A that produces erythrogenic toxin
Rash along with regular signs and symptoms
After 1 week, face begins to peel
S. pyogenes infection complications
notallinfections
Upper respiratory infections may become acute rheumatic fever
Pharyngitis or skin infections may become poststreptococcal glomerulonephritis
S. pyogenes: Diagnostic Eval
Throat culture
Rapid antigen test on throat swab
Molecular test for GAS
Serological tests
-demonstrate Abs & extracellular products
-Antistreptolysin O (ASO) and anti-deoxyribonuclease B (anti-Dnase B) standard
-Specimen pairing: compare acute and convalescent sera collected 3 weeks apart
S. pyogenes - Antistreptolysin O (serological test)
Ability of patient serum to neutralize erythrocyte-lysing capability of SLO
Titer rises ~7 days after infection onset, maxes out ~4-6 weeks (can have elevated titer for up to a year)
The rise in the titer over 1-2 weeks more significant than one titer
S. pyogenes - Deoxyribonuclease B (serological test)
Dnase B produced by S. pyogenes, not other streps.
Reliable Ab test for skin & throat infections.
50% patients with S. pyogenes acute glomerulonephris will have elevated Dnase B with normal ASO titer
LESS SUSCEPTIBLE TO FALSE POSITIVES THAN ASO due to bacterial growth in specimen, liver disease and oxidation of the antigen
S. pyogenes Toxic Shock Syndrome (STSS) - Etiology
Portal of entry unknown in 50% of cases
Has been associated with use of super tampons
Appears after cocci have invaded areas of injured skin
S. pyogenes Toxic Shock Syndrome (STSS) - Immunological Mechanisms
Pyrogenic exotoxins cause fever and help induce shock by lowering the threshold to exogenous endotoxin
Induction of cytokines in vivo is likely the cause of shock
S. pyogenes Toxic Shock Syndrome (STSS) - Epidemiology
Highest rates in young children and older adults
50+ % have underlying chronic illness
up to 70% mortality
rare infection, ~300 cases per year
S. pyogenes Toxic Shock Syndrome (STSS) - Signs & Symptoms
Fever, blotchy rash, red/swollen/pain on infected skin
Average incubation time 2-3 days
80% cases have clinical signs of soft tissue infection
20% have influenze like symptoms
S. pyogenes Toxic Shock Syndrome (STSS) - Laboratory Findings
Serological confirmation shows 4x rise against SLO(ASO) & Dnase B
Milk leukocytosis, immature neutrophils 40-50%
Positive blood cultures in 60% of cases
Hemoglobinuria & serum creatinine 2.5x normal (renal involvment)
S. pyogenes Toxic Shock Syndrome (STSS) - Treatment
IV fluids, blood pressure maintenance medication
Can be deadly, requires immediate treatment
Skin may peel as rash heals, may need to debride with surgery
Streptococcus agalactiae (Group B Strep) Disease - Epidemiology
Fatality rates 26-70% for men & non-pregnant women
30+% women asymptomatic carriers in genitourinary tract. Leading cause of early-onset neonatal sepsis in US
Universal screening at 35-37 weeks pregnancy, intrapartum antibiotics reduce GBS disease in newborns.
Streptococcus agalactiae (Group B Strep) Disease - Etiology
Gram positive
Streptococcus agalactiae (Group B Strep) Disease - Laboratory Data
Mostly isolated from blood
Latex test not as effective as culture or molecular
PCR assay from culture broth (commonly used)